FI883643A - Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna. - Google Patents

Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna. Download PDF

Info

Publication number
FI883643A
FI883643A FI883643A FI883643A FI883643A FI 883643 A FI883643 A FI 883643A FI 883643 A FI883643 A FI 883643A FI 883643 A FI883643 A FI 883643A FI 883643 A FI883643 A FI 883643A
Authority
FI
Finland
Prior art keywords
denotes
amino acid
slemhinnorna
cyklopeptider
befraemjar
Prior art date
Application number
FI883643A
Other languages
English (en)
Other versions
FI883643A0 (fi
Inventor
Juergen Kurt Sandow
Rainer Schmiedel
Klaus Wirth
Hans Peter Merkle
Susanne Raehs
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI883643A0 publication Critical patent/FI883643A0/fi
Publication of FI883643A publication Critical patent/FI883643A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI883643A 1987-08-07 1988-08-04 Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna. FI883643A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19873726324 DE3726324A1 (de) 1987-08-07 1987-08-07 Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute

Publications (2)

Publication Number Publication Date
FI883643A0 FI883643A0 (fi) 1988-08-04
FI883643A true FI883643A (fi) 1989-02-08

Family

ID=6333298

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883643A FI883643A (fi) 1987-08-07 1988-08-04 Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna.

Country Status (19)

Country Link
US (1) US5091365A (fi)
EP (1) EP0302466B1 (fi)
JP (1) JP2764930B2 (fi)
KR (1) KR970004039B1 (fi)
AT (1) ATE69556T1 (fi)
AU (1) AU608878B2 (fi)
CA (1) CA1331131C (fi)
DE (2) DE3726324A1 (fi)
DK (1) DK168273B1 (fi)
ES (1) ES2038725T3 (fi)
FI (1) FI883643A (fi)
GR (1) GR3003733T3 (fi)
HU (1) HU199301B (fi)
IE (1) IE60871B1 (fi)
IL (1) IL87362A0 (fi)
NO (1) NO179094C (fi)
NZ (1) NZ225715A (fi)
PT (1) PT88192B (fi)
ZA (1) ZA885724B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW274552B (fi) * 1992-05-26 1996-04-21 Hoechst Ag
DE69424940T2 (de) * 1993-06-29 2000-12-28 Ferring B.V., Hoofdorp Synthese zyklischer peptide
US5767068A (en) * 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
IT1294191B1 (it) * 1997-09-05 1999-03-22 Alfa Wassermann Spa Composizioni farmaceutiche contenenti calcitonina in un dosatore spray per somministrazione intranasale.
KR100611559B1 (ko) * 1998-05-08 2007-04-25 동아제약주식회사 칼시토닌을 함유한 비강투여용 약제학적 조성물
SE514606C2 (sv) * 1998-08-26 2001-03-19 Laekartjaenster I Vaestsverige Läkemedel innehållande GnRH-analoger för behandling av schizofreni
DE10014007A1 (de) * 2000-03-22 2001-10-11 Strathmann Ag & Co Neue Darreichungsformen für DSIP
US20020141970A1 (en) * 2001-03-05 2002-10-03 Pettit Dean K. Stable aqueous solutions of granulocyte macrophage colony-stimulating factor
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
CN109153712B (zh) 2016-04-19 2022-09-16 格里芬制药国际公司 Peg化生物活性肽及其用途
US20220226479A1 (en) * 2019-03-25 2022-07-21 University Of Tsukuba Cell layer permeation promoter. composition for facilitating drug absorption. and pharmaceutical composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171774D1 (en) * 1980-03-31 1985-09-19 Teijin Ltd Pharmaceutical composition for intrarectal administration, and suppository prepared therefrom
US4900730A (en) * 1981-01-14 1990-02-13 Toyo Jozo Co., Ltd. Preparation which promotes the absorption of peptides
JPS58140026A (ja) * 1982-01-14 1983-08-19 Toyo Jozo Co Ltd 吸収性良好な製剤
CA1188987A (en) * 1981-03-06 1985-06-18 Masataka Morishita Preparation having excellent absorption property
US4568665A (en) 1982-06-25 1986-02-04 Mitchell David C Protein compounds
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
CA1249968A (en) * 1984-04-05 1989-02-14 Kazuo Kigasawa Ointment base
US4537772A (en) * 1984-05-02 1985-08-27 Merck & Co., Inc. Enhancing absorption of drugs from gastrointestinal tract using acylcarnitines
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
DE3532074A1 (de) * 1985-09-09 1987-03-12 Berlin Chemie Veb Resorptionsvermittler fuer biologisch aktive peptide

Also Published As

Publication number Publication date
IL87362A0 (en) 1989-01-31
DK168273B1 (da) 1994-03-07
CA1331131C (en) 1994-08-02
KR970004039B1 (ko) 1997-03-24
DK440888D0 (da) 1988-08-05
NO883468L (no) 1989-02-08
ATE69556T1 (de) 1991-12-15
NO179094B (no) 1996-04-29
KR890003409A (ko) 1989-04-14
PT88192B (pt) 1995-03-01
JPS6466128A (en) 1989-03-13
HUT47599A (en) 1989-03-28
NO179094C (no) 1996-08-07
IE882408L (en) 1989-02-07
JP2764930B2 (ja) 1998-06-11
ZA885724B (en) 1989-04-26
AU2043388A (en) 1989-04-20
DK440888A (da) 1989-02-08
GR3003733T3 (fi) 1993-03-16
FI883643A0 (fi) 1988-08-04
NO883468D0 (no) 1988-08-04
US5091365A (en) 1992-02-25
EP0302466B1 (de) 1991-11-21
DE3726324A1 (de) 1989-02-16
HU199301B (en) 1990-02-28
IE60871B1 (en) 1994-08-24
PT88192A (pt) 1989-06-30
NZ225715A (en) 1991-02-26
ES2038725T3 (es) 1993-08-01
DE3866307D1 (de) 1992-01-02
EP0302466A1 (de) 1989-02-08
AU608878B2 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
SE8300736D0 (sv) Novel pharmacologically active compounds
LU91857I2 (fr) Abarelix, optionnellement sous forme de sel pharmaceutiquement acceptable
ES520226A0 (es) Procedimiento para la preparacion de derivados de cefem.
NZ225344A (en) 3-demethylmevalonic acid derivatives and lactones and pharmaceutical compositions; intermediates for the preparation thereof
ES2084579T3 (es) Uso de buspirona en la preparacion de una composicion farmaceutica para el tratamiento del abuso del alcohol.
FI883643A0 (fi) Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna.
DK0387821T3 (da) 2-Alkyl-4-arylmethylchinoliner, deres anvendelse og lægemidler fremstillet hermed
ZA832292B (en) Salicylic acid derivatives,processes for their preparation,pharmaceutical for mulations based on these compounds and their use
DK408083D0 (da) Isoquinilinderivater, deres fremstilling og anvendelse
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
SE8306225L (sv) 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma
ES2071636T3 (es) Uso de acidos oxapenem-3-carboxilicos estables para la fabricacion de medicamentos inhibidores de la b-lactamasa.
DK279988D0 (da) Spiro(4,5)decanderivater, fremgangsmaade til deres fremstilling og farmaceutiske midler indeholdende dem
PT82847B (pt) Processo para a preparacao de composicoes farmaceuticas contendo 4-amino-2-(imidazolodina-2-ona-1-il)-pirimidina-5-carboxil-(n-(3-trifluormetil-fenil)-amidas)
ES2104295T3 (es) Derivados ciclopeptidicos de la angiopeptina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK48489A (da) Heteroanellerede phenylglycin-beta-lactam-antibiotika og farmaceutisk acceptable salte deraf, deres fremstilling og anvendelse
SE8603517D0 (sv) Heterocyclic compounds and their preparation and pharmaceutical formulation
DK98788A (da) Benzylaminoaryl-dihydropyridinlactoner, fremgangmsaade til deres fremstilling samt deres anvendelse som laegemidler

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: HOECHST AKTIENGESELLSCHAFT